← back to search

Teresa M. Giret

University of Miami · US
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer Cells and Metastasis, Prostate Cancer Treatment and Research, Cancer Genomics and Diagnostics, and Cancer Immunotherapy and Biomarkers.
h-index
4
citations
85
works
12
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

ALCAM: A Novel Surface Marker on EpCAMlow Circulating Tumor Cells
Biomedicines 2022cited by 4position: middledoi
Circulating Tumor Cells from Enumeration to Analysis: Current Challenges and Future Opportunities
Cancers 2021cited by 47position: middledoi
Toward prediction of abscopal effect in radioimmunotherapy: Pre-clinical investigation
PLoS ONE 2021cited by 13position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Shweta Lavania · University of Miami1 papers (2022–2022)Benjamin Spieler · University of Miami1 papers (2021–2021)W. Andy Tao · Center for Cancer Research1 papers (2022–2022)Dazhi Wang · University of Miami1 papers (2021–2021)Daniel Bilbao Cortes · University of Miami1 papers (2022–2022)Aliya Khan · McMaster University1 papers (2022–2022)Scott M. Welford · University of Miami1 papers (2021–2021)Ayse Burcu Ergonul · University of Miami1 papers (2022–2022)Marco Hadisurya · Purdue University West Lafayette1 papers (2022–2022)Mónica García-Buitrago · University of Miami1 papers (2022–2022)Ashley Middleton · Old Dominion University1 papers (2022–2022)Rossana Signorelli · University of Miami1 papers (2022–2022)Oliver Umland · University of Miami1 papers (2022–2022)Melinda Boone · University of Miami1 papers (2022–2022)Haleh Amirian · University of Miami1 papers (2022–2022)Harrys K.C. Jacob · Sylvester Comprehensive Cancer Center1 papers (2022–2022)Robert Diaz · Stanford University1 papers (2022–2022)Richard J. Côté · Washington University in St. Louis1 papers (2021–2021)Yu-Ping Yang · University of Miami1 papers (2021–2021)Tulasigeri M. Totiger · University of Miami1 papers (2021–2021)